Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Biophytis
- Target Recruit Count
- 238
- Registration Number
- NCT04472728
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸United Health Services Hospitals, Johnson City, New York, United States
🇧🇪CHU Saint-Pierre, Brussel, Belgium
A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)
Phase 2
Completed
- Conditions
- SarcopeniaGait Disorders in Old AgeMuscle Weakness
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Biophytis
- Target Recruit Count
- 233
- Registration Number
- NCT03452488
- Locations
- 🇺🇸
PANAX Clinical Research, Miami Lakes, Florida, United States
🇺🇸Jean Mayer USDA Human Nutrition research Center on Aging Tufts University, Boston, Massachusetts, United States
🇧🇪Vrije Universiteit Brussel, Bruxelles, Belgium
An OBServational Clinical Trial (SARA-OBS) in Sarcopenia and Sarcopenic Obesity in Patients Aged 65 Years and Over
Completed
- Conditions
- Muscle WeaknessSarcopeniaGait Disorders in Old Age
- First Posted Date
- 2017-01-16
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Biophytis
- Target Recruit Count
- 218
- Registration Number
- NCT03021798
- Locations
- 🇧🇪
Université de Liège, Liège, Belgium
🇺🇸Institut On Aging, Gainesville, Florida, United States
🇺🇸Columbia University New York, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath